Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 699

1.

Dabigatran etexilate and LMWH for the prevention of venous thromboembolism in 532 patients undergoing hip surgery.

Bonarelli S, Bacchin MR, Frugiuele I, Feoli MA, Facchini F, Altimari V.

Eur Rev Med Pharmacol Sci. 2015 Mar;19(5):897-903.

PMID:
25807444
2.

Development and validation of LC-MSMS assay for the determination of the prodrug dabigatran etexilate and its active metabolites in human plasma.

Nouman EG, Al-Ghobashy MA, Lotfy HM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Mar 7;989:37-45. doi: 10.1016/j.jchromb.2015.02.042. [Epub ahead of print]

PMID:
25797721
3.

A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran.

Glund S, Moschetti V, Norris S, Stangier J, Schmohl M, van Ryn J, Lang B, Ramael S, Reilly P.

Thromb Haemost. 2015 Mar 19;113(5). [Epub ahead of print]

PMID:
25789661
4.

[Management of direct oral anticoagulants for invasive procedures].

Godier A, Gouin-Thibault I, Rosencher N, Albaladejo P; Groupe d’intérêt en hémostase périopératoire (GIHP).

J Mal Vasc. 2015 Mar 13. pii: S0398-0499(15)00078-5. doi: 10.1016/j.jmv.2015.02.004. [Epub ahead of print] French.

PMID:
25778841
5.

Stability of Dabigatran Etexilate in Manufacturer's Blister Pack, Unit-Dose Packaging, and Community Pharmacy Blister Pack.

Wang EH, Bolt JL, Décarie D, Semchuk W, Ensom MH.

Can J Hosp Pharm. 2015 Jan-Feb;68(1):16-21.

PMID:
25762815
6.
7.

Assessing the anticoagulant effect of dabigatran in children: An in vitro study.

Dietrich K, Stang L, van Ryn J, Mitchell LG.

Thromb Res. 2015 Apr;135(4):630-5. doi: 10.1016/j.thromres.2015.01.017. Epub 2015 Jan 17.

8.

More indications approved and safety news for dabigatran etexilate.

Cinteza M.

Maedica (Buchar). 2014 Dec;9(4):405-7. No abstract available.

9.

Dabigatran etexilate as second-line therapy in patients with a left ventricular assist device.

Terrovitis JV, Ntalianis A, Kapelios CJ, Vakrou S, Diakos N, Katsaros L, Tsamatsoulis M, Kaldara E, Charitos C, Nanas JN.

Hellenic J Cardiol. 2015 Jan-Feb;56(1):20-5.

10.

What is the role of hemodialysis for dabigatran-associated major bleeding?

Kim B, Garcia DA.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):514-7. doi: 10.1182/asheducation-2014.1.514. Epub 2014 Nov 18.

PMID:
25696903
11.

Comparison of Renoprotective Effect of Dabigatran With Low-Molecular-Weight Heparin.

Yazici S, Karahan O, Oral MK, Bayramoğlu Z, Unal M, Caynak B, Sagbas E.

Clin Appl Thromb Hemost. 2015 Feb 13. pii: 1076029615571629. [Epub ahead of print]

PMID:
25681331
12.

Acute pulmonary embolism: risk assessment, risk stratification and treatment options.

Piovella F, Iosub DI.

Clin Respir J. 2015 Jan 26. doi: 10.1111/crj.12264. [Epub ahead of print]

PMID:
25619266
13.

Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban.

Stöllberger C, Finsterer J.

Herz. 2015 Jan 25. [Epub ahead of print]

PMID:
25616425
14.

Identification and Management of Noncompliance in Atrial Fibrillation Patients Receiving Dabigatran: The Role of a Drug Monitor.

Hu YF, Liao JN, Chern CM, Weng CH, Lin YJ, Chang SL, Wu CH, Sung SH, Wang KL, Lu TM, Chao TF, Lo LW, Chung FP, Hsu LC, Chen SA.

Pacing Clin Electrophysiol. 2015 Jan 20. doi: 10.1111/pace.12575. [Epub ahead of print]

PMID:
25601592
15.

Measurement of dabigatran plasma concentrations by calibrated thrombin clotting time in comparison to LC-MS/MS in human volunteers on dialysis.

Schmohl M, Gansser D, Moschetti V, Stangier J.

Thromb Res. 2015 Mar;135(3):532-6. doi: 10.1016/j.thromres.2014.12.021. Epub 2015 Jan 2.

PMID:
25600440
16.

Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study.

Gorst-Rasmussen A, Skjøth F, Larsen TB, Rasmussen LH, Lip GY, Lane DA.

J Thromb Haemost. 2015 Jan 16. doi: 10.1111/jth.12845. [Epub ahead of print]

PMID:
25594442
17.

Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.

Honickel M, Treutler S, van Ryn J, Tillmann S, Rossaint R, Grottke O.

Thromb Haemost. 2015 Jan 8;113(4). [Epub ahead of print]

PMID:
25567155
18.

Generation of an anti-dabigatran monoclonal antibody and its employment in a highly sensitive and specific enzyme-linked immunosorbent assay for serum dabigatran.

Oiso S, Morinaga O, Goroku T, Uto T, Shoyama Y, Kariyazono H.

Ther Drug Monit. 2015 Jan 6. [Epub ahead of print]

PMID:
25565675
19.

Left atrial appendage thrombus with resulting stroke post-RF ablation for atrial fibrillation in a patient on dabigatran.

Lobo R, McCann C, Hussaini A, Meany TB, Kiernan TJ.

Ir Med J. 2014 Nov-Dec;107(10):329-30.

PMID:
25551903
20.

[Fatal bleeding diarrhoea during dabigatran etexilate therapy.]

Nyby S, Hennes O.

Ugeskr Laeger. 2014 Dec 15;176(51). pii: V09140482. Danish.

PMID:
25534224
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk